Search results
MoonLake Immunotherapeutics Reports Q1 2024 Financial Outcomes
Guru Focus· 10 hours agoReported Net Loss: $13.98 million for Q1 2024, below the estimated net loss of $13.21 million.Earnings Per Share (EPS): Recorded a loss of $0.22 per share, bel
Janssen-Cilag seeks expanded EMA approval for TREMFYA
Pharmaceutical Technology via Yahoo Finance· 6 days agoGuselkumab has been approved in the EU to treat moderate to severe plaque psoriasis in adults who...
13 Times Met Gala Attendees Took "Beauty Is Pain" Way Too Seriously And Wore Looks That Physically...
BuzzFeed via Yahoo News· 4 days agoFor Kim Kardashian, wearing her famous Mugler "wet look" dress was one of the most painful...
Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
Zacks via Yahoo Finance· 5 days agoKymera (KYMR) reports a narrower-than-expected loss in the first quarter. The company expects the...
Consolidated Planning Corp Sells 1,063 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 6 days agoConsolidated Planning Corp lessened its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 3.5% in the 4th quarter, HoldingsChannel.com reports. The fund owned 29,072 shares of ...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 5 days agoTremfya is presently approved to treat certain patients with plaque psoriasis and active psoriatic ...
LGT Group Foundation Cuts Holdings in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 1 day agoLGT Group Foundation cut its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 2.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities ...
Q2 2024 EPS Estimates for Amgen Inc. Reduced by Leerink Partnrs (NASDAQ:AMGN)
ETF DAILY NEWS· 1 day agoAmgen Inc. (NASDAQ:AMGN – Free Report) – Stock analysts at Leerink Partnrs reduced their Q2 2024 earnings estimates for Amgen in a research report issued on Friday, May 3rd. Leerink Partnrs ...
How a Florida man overcame a broken femur, fractured pelvis and now heart disease
Tampa Bay Times· 6 days agoLast month, 50 years of bike riding, running and pretending I’m Arnold Schwarzenegger in the gym failed me. With three grandparents dying of heart disease, I knew all along I was doomed. Late ...
Amgen (NASDAQ:AMGN) Shares Down 2.7% on Insider Selling
ETF DAILY NEWS· 1 day agoAmgen Inc. (NASDAQ:AMGN – Get Free Report) shares were down 2.7% on Monday after an insider sold shares in the company. The company traded as low as $301.09 and last traded at $302.91. Specifically ...